Current Ratio of Landos Biopharma, Inc. from 30 Sep 2021 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Landos Biopharma, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 31 Mar 2024.
  • Landos Biopharma, Inc. Current Ratio for the quarter ending 31 Mar 2024 was 730%, a 20% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Landos Biopharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q1 2024 730% -186% -20% 31 Mar 2024
Q4 2023 941% +257% +37% 31 Dec 2023
Q3 2023 986% +358% +57% 30 Sep 2023
Q2 2023 1024% +357% +53% 30 Jun 2023
Q1 2023 916% +214% +30% 31 Mar 2023
Q4 2022 685% -180% -21% 31 Dec 2022
Q3 2022 628% -204% -24% 30 Sep 2022
Q2 2022 667% 30 Jun 2022
Q1 2022 702% 31 Mar 2022
Q4 2021 864% 31 Dec 2021
Q3 2021 832% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.